TRJ Stock Overview
Develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for TRJ from our risk checks.
Trajan Group Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$1.24 |
| 52 Week High | AU$1.34 |
| 52 Week Low | AU$0.68 |
| Beta | 0.69 |
| 11 Month Change | 9.25% |
| 3 Month Change | 22.77% |
| 1 Year Change | 8.30% |
| 33 Year Change | -57.09% |
| 5 Year Change | n/a |
| Change since IPO | -37.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| TRJ | AU Life Sciences | AU Market | |
|---|---|---|---|
| 7D | -0.4% | 0.7% | -0.7% |
| 1Y | 8.3% | 28.2% | 17.1% |
Return vs Industry: TRJ underperformed the Australian Life Sciences industry which returned 28.2% over the past year.
Return vs Market: TRJ underperformed the Australian Market which returned 17.1% over the past year.
Price Volatility
| TRJ volatility | |
|---|---|
| TRJ Average Weekly Movement | 7.9% |
| Life Sciences Industry Average Movement | 10.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 3.6% |
Stable Share Price: TRJ has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: TRJ's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 600 | Stephen Tomisich | www.trajanscimed.com |
Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including syringes, GC columns and septa, rings, inlet liners, and tubing products; pathology products, consisting of NBF containers, adhesive and frosted microscope slides, coverslips, slide storage trays/mailers, cassette storage boxes, biopsy pads, histology wax plus, microtome blades, and marking dyes and sets, and MiPlatform, a smartphone adapter. It also provides sampling products, comprising septa, caps, liners, crimping tools, well plates and sealing mats, and micro sampling tools, as well as automation systems for the analysis of biological, food, and environmental samples.
Trajan Group Holdings Limited Fundamentals Summary
| TRJ fundamental statistics | |
|---|---|
| Market cap | AU$188.80m |
| Earnings (TTM) | -AU$25.33m |
| Revenue (TTM) | AU$155.02m |
1.2x
P/S Ratio-7.5x
P/E RatioIs TRJ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TRJ income statement (TTM) | |
|---|---|
| Revenue | AU$155.02m |
| Cost of Revenue | AU$95.27m |
| Gross Profit | AU$59.75m |
| Other Expenses | AU$85.08m |
| Earnings | -AU$25.33m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.17 |
| Gross Margin | 38.55% |
| Net Profit Margin | -16.34% |
| Debt/Equity Ratio | 42.9% |
How did TRJ perform over the long term?
See historical performance and comparison